Physician profile
Cameron L Smith
NPI 1770504060
$1,679.59
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $86.58 · 2021: $1,088 · 2022: $123.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $800.00 | 2021 | |
| Abbvie INC. | $204.94 | 2019-2022 | |
| Amgen INC. | $177.13 | 2021-2022 | |
| Celgene Corporation | $139.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $80.79 | 2019-2020 | |
| Pfizer INC. | $50.16 | 2019-2021 | |
| Boston Scientific Corporation | $41.37 | 2019-2020 | |
| Genzyme Corporation | $35.87 | 2019-2020 | |
| Leo Pharma INC. | $31.58 | 2019-2022 | |
| Biofrontera INC. | $25.48 | 2019-2021 | |
| Lilly USA, LLC | $18.31 | 2021 | |
| Dusa Pharmaceuticals, INC. | $16.73 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.14 | 2021 | |
| Genentech USA, INC. | $15.63 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $11.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.